Abstract:Aims Obesity always leads to profound perturbation of metabolome. Metabolome studies enrich the knowledge on associations between endogenous metabolites and obesity, potentially providing innovative strategies for the development of novel anti‐obesity pharmacotherapy. This study aims to identify an endogenous metabolite that regulates energy expenditure and to explore its application for obesity treatment. Materials and Methods C57BL/6 mice were fed with a high‐fat and high‐cholesterol (HFC) diet, comprising 60% fat and 1.2% cholesterol, for 12 weeks to induce obesity. Significant metabolites were identified in the livers of both health and obese mice through comparative hepatic metabolomics analysis. Correlation between serum or adipose L‐aspartate level and body weight in obese mice, as well as human body mass index (BMI), was evaluated. In addition, saline or 200 mg/kg L‐aspartate was orally administrated to HFC diet mice and HFC diet‐induced obese mice for 6–7 weeks. Body weight, adipose tissue weight, glucose tolerance and liver damage were assessed to evaluate the effect on obesity prevention and treatment. Comprehensive lab animal monitoring system (CLAMS) and seahorse assay were employed to investigate the regulatory effect of L‐aspartate on energy metabolism in vivo and in vitro, respectively. 3T3‐L1 preadipocytes and murine white adipose tissue (WAT) were utilized to examine the impact of L‐aspartate on adipocyte adipogenesis and lipogenesis and cellular signalling pathway in vitro and in vivo. Results L‐aspartate, an approved drug for liver injury and chronic fatigue, was identified as an endogenous inducer of energy expenditure. Serum or adipose L‐aspartate levels were found to be negatively correlated with the severity of obesity in both humans and mice. Administration of L‐aspartate to HFC diet mice led to a significant reduction in body weight, with decreases of 14.5% in HFC diet mice and 8.5% in HFC diet‐induced obese mice, respectively. In addition, the treatment improved related metabolic syndrome (Figure 2 and Figure S3). These therapeutics were associated with enhancements in whole‐body energy expenditure and suppression of adipocyte adipogenesis along with activation of Adenosine 5′‐monophosphate‐activated protein kinase (AMPK) signalling pathway. Conclusion L‐aspartate may serve as a novel endogenous inducer of energy expenditure and suppressor of adipogenesis and lipogenesis along with activation of AMPK, thereby offering a promising therapeutic strategy for obesity prevention and treatment.

Dietary D-lactate Intake Ameliorates Metabolic Syndrome Via Enhancing Brown Adipose Tissue Thermogenesis in Diet-Induced Obese Mice

Moderate l-lactate administration suppresses adipose tissue macrophage M1 polarization to alleviate obesity-associated insulin resistance

Dietary supplementation of L-carnitine ameliorates metabolic syndrome independent of trimethylamine N-oxide produced by gut microbes in high fat diet induced obese mice

DHA/EPA Improves GLUT4 Translocation, Glycogen Synthesis and Aerobic Glycolysis in Skeletal Muscle of Db/db Mice

Succinic Acid Improves the Metabolism of High-Fat Diet-Induced Mice and Promotes White Adipose Browning

The different effects of intramuscularly-injected lactate on white and brown adipose tissue in vivo

Lactobacillus delbrueckii subsp. lactis CKDB001 Ameliorates Metabolic Complications in High-Fat Diet-Induced Obese Mice

Lactobacillus acidophilus JYLA-126 Ameliorates Obesity-Associated Metabolic Disorders by Positively Regulating the AMPK Signaling Pathway Through the Gut-Liver Axis

Lactate Conversion by Lactate Dehydrogenase B Is Involved in Beige Adipocyte Differentiation and Thermogenesis in Mice

L‐aspartate ameliorates diet‐induced obesity by increasing adipocyte energy expenditure

Lactate induces the development of beige adipocytes via an increase in the level of reactive oxygen species

Lactate promotes fatty acid oxidation by the tricarboxylic acid cycle and mitochondrial respiration in muscles of obese mice

Activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model

Lactate coordinated with exercise promoted the browning of inguinal white adipose tissue

Gentisic Acid Prevents Diet-Induced Obesity In Mice By Accelerating The Thermogenesis Of Brown Adipose Tissue

Metformin plus L-carnitine enhances brown/beige adipose tissue activity via Nrf2/HO-1 signaling to reduce lipid accumulation and inflammation in murine obesity

Succinate Enhances Lipolysis and Decreases Adipocytes Size in Both Subcutaneous and Visceral Adipose Tissue from High-Fat-Diet-Fed Obese Mice

The synergism of Lactobacillaceae, inulin, polyglucose, and aerobic exercise ameliorate hyperglycemia by modulating the gut microbiota community and the metabolic profiles in db/db mice

Metabolomics Insights into the Modulatory Effects of Long-Term Compound Polysaccharide Intake in High-Fat Diet-Induced Obese Rats

A combined metabolomics and molecular biology approach to reveal hepatic injury and underlying mechanisms after chronic l-lactate exposure in mice

Hepatic DsbA‐L Protects Mice from Diet‐induced Hepatosteatosis and Insulin Resistance